UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.071

Sortiert nach

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

JNCI : Journal of the National Cancer Institute, 2012-10, Vol.104 (19), p.1503-1513

2012

Volltextzugriff (PDF)

L2, the minor capsid protein of papillomavirus

Virology (New York, N.Y.), 2013-10, Vol.445 (1), p.175-186

2013

Volltextzugriff (PDF)

Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer

PloS one, 2024-07, Vol.19 (7), p.e0305710

2024

Volltextzugriff (PDF)

Immunizing against Anogenital Cancer: HPV Vaccines

PLoS pathogens, 2016-05, Vol.12 (5), p.e1005587-e1005587

2016

Volltextzugriff (PDF)

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor

PloS one, 2023-06, Vol.18 (6), p.e0285221

2023

Volltextzugriff (PDF)

Immunologic Control of Mus musculus Papillomavirus Type 1

PLoS pathogens, 2015-10, Vol.11 (10), p.e1005243-e1005243

2015

Volltextzugriff (PDF)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

mBio, 2021-01, Vol.12 (1)

2021

Volltextzugriff (PDF)

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

Journal of Virology, 2007-12, Vol.81 (24), p.13927-13931

2007

Volltextzugriff (PDF)

Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth

Clinical cancer research, 2006-08, Vol.12 (16), p.4933-4939

2006

Volltextzugriff (PDF)

EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO

Journal of virology, 2021-03, Vol.95 (8)

2021

Volltextzugriff (PDF)

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1049-1062

2021

Volltextzugriff (PDF)

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung

The American journal of surgical pathology, 2012-10, Vol.36 (10), p.1472-1476

2012

Volltextzugriff (PDF)

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

Journal of Virology, 2008-05, Vol.82 (9), p.4638-4646

2008

Volltextzugriff (PDF)

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

PloS one, 2021-09, Vol.16 (9), p.e0256937-e0256937

2021

Volltextzugriff (PDF)

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study

Breast cancer research : BCR, 2018-11, Vol.20 (1), p.134-10, Article 134

2018

Volltextzugriff (PDF)

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Clinical cancer research, 2014-06, Vol.20 (12), p.3174-3186

2014

Volltextzugriff (PDF)

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

JNCI : Journal of the National Cancer Institute, 2009-06, Vol.101 (11), p.782-792

2009

Volltextzugriff (PDF)

Virus-like particles for the prevention of human papillomavirus-associated malignancies

Expert review of vaccines, 2013-02, Vol.12 (2), p.129-141

2013

Volltextzugriff (PDF)

Optimization of multimeric human papillomavirus L2 vaccines

PloS one, 2013-01, Vol.8 (1), p.e55538-e55538

2013

Volltextzugriff (PDF)

Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

The American journal of pathology, 2011-10, Vol.179 (4), p.1608-1615

2011

Volltextzugriff (PDF)

Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice

mBio, 2022-02, Vol.13 (1), p.e0325221

2022

Volltextzugriff (PDF)

Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches

Journal of Virology, 2010-02, Vol.84 (3), p.1214-1220

2010

Volltextzugriff (PDF)

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

PloS one, 2012-06, Vol.7 (6), p.e39741-e39741

2012

Volltextzugriff (PDF)

Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2

Journal of Virology, 2007-11, Vol.81 (21), p.11585-11592

2007

Volltextzugriff (PDF)

1 – 25 von 1.071

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(932)
Mit Volltextzugriff
(900)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.038)
Japanisch
(170)
Deutsch
(23)
Französisch
(9)
Russisch
(2)
Norwegisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(707)
Life Sciences & Biomedicine
(593)
Humans
(484)
Female
(292)
Male
(235)
Biological And Medical Sciences
(185)
Animals
(181)
Middle Aged
(155)
Adult
(144)
Medical Sciences
(140)
Aged
(100)
Mice
(88)
Risk Factors
(81)
Pharmacology & Pharmacy
(79)
Cardiovascular System & Cardiology
(74)
Physical Sciences
(72)
Cardiac & Cardiovascular Systems
(67)
Endocrinology & Metabolism
(67)
Fundamental And Applied Biological Sciences. Psychology
(67)
Human Papillomavirus
(65)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

L2, the minor capsid protein of papillomavirus

Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer

Immunizing against Anogenital Cancer: HPV Vaccines

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor

Immunologic Control of Mus musculus Papillomavirus Type 1

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth

EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study

Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

Virus-like particles for the prevention of human papillomavirus-associated malignancies

Optimization of multimeric human papillomavirus L2 vaccines

Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice

Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2

Suchergebnisse filtern